Nikita Pozdeyev, MD

Recognitions

• Endocrine Society Presidential Poster Competition Winner, Endocrine Society (2014)
  
• Chief Resident, Medstar Harbor Hospital (2011)
  
• Intern of the Year Award, Medstar Harbor Hospital (2011)
  

Publications

• Pozdeyev N, Berlinberg A, Zhou Q, Wuensch K, Shibata H, Wood WM, Haugen BR. Targeting the NF-?B Pathway as a Combination Therapy for Advanced Thyroid Cancer. PLoS One. 2015;10(8):e0134901. PubMed PMID: 26263379
• Albuja-Cruz MB, Pozdeyev N, Robbins S, Chandramouli R, Raeburn CD, Klopper J, Haugen BR, McIntyre R Jr. A "safe and effective" protocol for management of post-thyroidectomy hypocalcemia. Am J Surg. 2015 Dec;210(6):1162-9. PubMed PMID: 26601651
• Pozdeyev N, Lund G, McDermott M. Thyroid Cancer. 3rd ed. Wartofsky L, Van Nostrand D, editors. in press: Springer; 2015. Molecular Pathogenesis of Thyroid Cancer and Oncogenes in Thyroid Cancer.
• Pozdeyev N, Yoo M, Mackie R, Schweppe RE, Tan AC, Haugen BR. Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies. Oncotarget. 2016 Aug 9;7(32):51619-51625. PubMed PMID: 27322211
• Kiseljak-Vassiliades K, Zhang Y, Bagby S, Kar A, Pozdeyev N, Xu M, Gowan K, Sharma V, Raeburn CD, Albuja-Cruz M, Jones KL, Fishbein L, Schweppe R, Somerset HL, Pitts TM, Leong S, Wierman M. Development of new preclinical models to advance adrenocortical carcinoma research. Endocr Relat Cancer. 2018 Jan 25. [Epub ahead of print] PubMed PMID: 29371329
• Kim MK, Aung MH, Mees L, Olson DE, Pozdeyev N, Iuvone PM, Thule PM, Pardue MT. Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice. Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):572-581. PubMed PMID: 29372256
• Pozdeyev N, Erickson TA, Zhang L, Ellison K, Rivard CJ, Sams S, Hirsch FR, Haugen BR, French JD. Comprehensive Immune Profiling of Medullary Thyroid Cancer. Thyroid. 2020 Sep;30(9):1263-1279. PubMed PMID: 32242507
• Schreiber AR, Kar A, Goodspeed AE, Pozdeyev N, Somerset H, Raeburn CD, Tan AC, Leong S, Wierman ME, Kiseljak-Vassiliades K. Leptomeningeal Metastasis from Adrenocortical Carcinoma: A Case Report. J Endocr Soc. 2020 Mar 1;4(3):bvaa017. PubMed PMID: 32154490
• Pozdeyev N, Rose MM, Bowles DW, Schweppe RE. Molecular therapeutics for anaplastic thyroid cancer. Semin Cancer Biol. 2020 Apr;61:23-29. PubMed PMID: 31991166
• Pozdeyev N, Patel A, Pottinger PS, Leu M, Payne TH. Adherence to Recommended Post-Splenectomy Immunizations to Reduce the Risk of Sepsis: The University of Washington Experience. Am J Med Qual. 2020 Sep Oct;35(5):405-410. PubMed PMID: 31941343
• Kahn MG, Mui JY, Ames MJ, Yamsani AK, Pozdeyev N, Rafaels N, Brooks IM. Migrating a research data warehouse to a public cloud: challenges and opportunities. J Am Med Inform Assoc. 2021 Dec 17. [Epub ahead of print] PubMed PMID: 34919694
• Pozdeyev N, Fishbein L, Gay LM, Sokol ES, Hartmaier R, Ross JS, Darabi S, Demeure MJ, Kar A, Foust LJ, Koc K, Bowles DW, Leong S, Wierman ME, Kiseljak-Vassiliades K. Targeted genomic analysis of 364 adrenocortical carcinomas. Endocr Relat Cancer. 2021 Aug 16;28(10):671-681. PubMed PMID: 34410225
• Alzofon N, Koc K, Panwell K, Pozdeyev N, Marshall CB, Albuja-Cruz M, Raeburn CD, Nathanson KL, Cohen DL, Wierman ME, Kiseljak-Vassiliades K, Fishbein L. Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression. Mol Cancer Res. 2021 Sep;19(9):1476-1485. PubMed PMID: 33986121
• Hicks HM, McKenna LR, Espinoza VL, Pozdeyev N, Pike LA, Sams SB, LaBarbera D, Reigan P, Raeburn CD, E Schweppe R. Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo. Mol Carcinog. 2021 Mar;60(3):201-212. PubMed PMID: 33595872
• Kahn MG, Mui JY, Ames MJ, Yamsani AK, Pozdeyev N, Rafaels N, Brooks IM. Migrating a research data warehouse to a public cloud: challenges and opportunities. J Am Med Inform Assoc. 2022 Mar 15;29(4):592-600. PubMed PMID: 34919694
• Rose MM, Espinoza VL, Hoff KJ, Pike LA, Sharma V, Hofmann M, Tan AC, Pozdeyev N, Schweppe RE. BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer. Cancers, Dec 2022
• Stoffel M, Desai S, Laine M, Leu MG, Liao ZC, Jang J, Singh AP, Pozdeyev N, Sutton PR, Wright A, White AA. Lessons learned from creating alert governance during an electronic health record transition. ACI Open 2022;6:e50–e56.
• Wiley LK et al., including Pozdeyev N. Building a Vertically-Integrated Genomic Learning Health System: The Colorado Center for Personalized Medicine Biobank. medRxiv 2022.06.09.22276222; doi: https://doi.org/10.1101/2022.06.09.22276222
• Mathur P et al., including Pozdeyev N. Artificial Intelligence in Healthcare: 2021 Year in Review. ResearchGate. February 2022, DOI: 10.13140/RG.2.2.25350.24645/1.
• Pozdeyev N, Dighe M, Barrio M, Raeburn C, Smith H, Fisher M, Chavan S, Rafaels N, Shortt JA, Lin M, Leu MG, Clark T, Marshall C, Haugen BR, Subramanian D, Crooks K, Gignoux C, Cohen T. Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant. J Clin Endocrinol Metab. 2023 Sep 8. [Epub ahead of print] PubMed PMID: 37683082
• Hicks HM, Pozdeyev N, Sams SB, Pugazhenthi U, Bales ES, Hofmann MC, McKenna LR, Schweppe RE. Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2. Mol Cancer Res. 2023 Sep 1;21(9):867-880. PubMed PMID: 37219859
• Barrio M, Raeburn CD, McIntyre R , Jr, Albuja-Cruz M, Haugen BR, Pozdeyev N. Computer-Assisted Levothyroxine Dose Selection for the Treatment of Postoperative Hypothyroidism. Thyroid. 2023 May;33(5):547-555. PubMed PMID: 37084246
• Rose MM, Espinoza VL, Hoff KJ, Pike LA, Sharma V, Hofmann MC, Tan AC, Pozdeyev N, Schweppe RE. BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer. Cancers (Basel). 2023 Jan 6;15(2). PubMed PMID: 36672327

Professional Memberships

• Endocrine Society, Member
• American Thyroid Association (ATA) , Member
• American Association of Clinical Endocrinologists (AACE), Member

Practice Locations

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-0000

UCHealth Diabetes and Endocrinology Clinic - Anschutz Medical Campus
1635 Aurora Ct
6th Floor
Aurora, CO 80045
720-848-2650

UCHealth Thyroid Cancer Multidisciplinary Clinic - Anschutz Medical Campus
1635 Aurora Court
Anschutz Outpatient Pavilion, 6th floor
Aurora, CO 80045
720-848-3299

Hospital Affiliation

• University of Colorado Hospital

Specialty Information

Specialties

• Endocrinology, Diabetes and Metabolism, Board Certification (2014)

Conditions & Treatments

• Endocrine System (Hormones) - Adult Type 1 Diabetes
• Endocrine System (Hormones) - Adult Type 2 Diabetes
• Endocrine System (Hormones) - Endocrine Cancer (Parathyroid, Adrenal, Carcinoid)
• Endocrine System (Hormones) - Thyroid Cancer
• Endocrine System (Hormones) - Thyroid Disease
• Endocrine System (Hormones) - Adrenal Diseases
• Endocrine System (Hormones) - Lipidosis
• Endocrine System (Hormones) - Osteoporosis
• Endocrine System (Hormones)